134790 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-08-01 |
| Register Year | 2014 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | DENOSUMAB |
| Trade Name | XGEVA 120 mg solution for injection |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Solution for injection |
| Administration Route | Subcutaneous use |
| Atc Code1 | M05BX04 |
| Atc Code2 | |
| Size | 1.7 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $1623 |
| Shelf Life | 36 Months |
| Marketing Company | AMGEN EUROPE B.V. |
| Marketing Country | Netherlands |
| Manufacture Name | AMGEN MANUFACTURING LIMITED |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | Cigalah Group |
| Secosnd Agent | |
| Third Agent | |
| Visits | 134790 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| XGEVA 120 mg solution for injection | $1623 | 134790 visits | 2022-08-01 |
| PROLIA 60MG/ML SOLUTION FOR INJECTION | $974 | 230551 visits | 2022-08-29 |